Theranostic Agents in Musculoskeletal Disorders

PET Clin. 2021 Jul;16(3):441-448. doi: 10.1016/j.cpet.2021.03.008.

Abstract

Theranostic-based strategies, combining therapeutic and diagnostic properties of a single agent, have gained enormous attention in the past few years. Today, various multifunctional theranostic modalities have been examined, using different bioactive targeting, for the detection, quantifying, and monitoring of therapy response in different pathologies. Herein we review the newly emerging approaches in theranostic nanomedicine for the detection and therapy for musculoskeletal disorders to provide valuable insights for developing more efficient agents for clinical use. Some potential preclinical applications of radionuclide nanotheranostic agents are described in rheumatoid arthritis, osteoarthrosis, multiple myeloma, and neoplastic diseases.

Keywords: Glucocorticoid-loaded liposomes; Macrophage imaging; Multiple myeloma; Osteoarthrosis; Radiolabeled anti-CD38 antibodies; Rheumatoid arthritis; Sarcoma; Theranostics.

Publication types

  • Review

MeSH terms

  • Arthritis, Rheumatoid*
  • Humans
  • Neoplasms*
  • Precision Medicine
  • Theranostic Nanomedicine